Skip to main navigation Skip to search Skip to main content

Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients with Levodopa-Induced Dyskinesias (the SPLENDID Study)

  • C. Warren Olanow
  • , Philippe Damier
  • , Christopher G. Goetz
  • , Thomas Mueller
  • , John Nutt
  • , Olivier Rascol
  • , Alexandru Serbanescu
  • , Frieda Deckers
  • , Hermann Russ

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)58-62
Number of pages5
JournalClinical neuropharmacology
Volume27
Issue number2
DOIs
StatePublished - 2004

Keywords

  • Parkinson disease
  • SPLENDID
  • Sarizotan

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Pharmacology

Cite this